Elagolix is a gonadotropin-releasing hormone (GnRH) antagonist approved for treating moderate to severe pain associated with endometriosis. 1-[[2-Fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione is a pharmaceutical intermediate employed to synthesize the drug Elagolix.
1-[[2-Fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione
| API Name | Elagolix |
|---|---|
| CAS No | 830346-47-9 |
| Molecular Formula | C13H10F4N2O2 |
| Molecular Weight | 302.22 g/mol |
| Synonyms | 1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione |
Zoho Contact Form
"*" indicates required fields